Contracts

Information is courtesy of the Office of Sponsored Projects. Each listing includes the faculty member’s name and school(s) appointments at The University of Texas Health Science Center at Houston, contracting agency, contract amount and title.

Rajesh Balkrishnan, School of Public Health and Graduate School of Biomedical Sciences (GSBS), Takeda Pharnaceuticals North America Inc., $40,300, Factors Affecting Physician Prescription of Medications for Sleep Disorders: Analysis of U.S. National Practice Data.

Ronald Portman, Medical School (MS), Astra/Zeneca, L.P., $91,000, Dose-Ranging and Safety Study of Candesartan.

Alan Swann, MS and GSBS, Abbott Laboratories, $110,240, A Randomized, Double-Blind Study of Depakote Monotherapy, Olazapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness.

Adel A.Wassef, MS, Organon Pharmaceuticals USA Inc., $290,130, An Assessment of the Efficacy and Safety of Two Sublingual Doses of Org 5222 in Schii.